1. Untangling the R2* contrast in multiple sclerosis: A combined MRI-histology study at 7.0 Tesla
- Author
-
Bagnato, Francesca, Hametner, Simon, Boyd, Emma, Endmayr, Verena, Shi, Yaping, Ikonomidou, Vasiliki, Chen, Guanhua, Pawate, Siddharama, Lassmann, Hans, Smith, Seth, and Welch, E Brian
- Subjects
Neurodegenerative ,Biomedical Imaging ,Brain Disorders ,Neurosciences ,Autoimmune Disease ,Multiple Sclerosis ,Neurological ,Aged ,Aged ,80 and over ,Brain ,Contrast Media ,Female ,Humans ,Imaging ,Three-Dimensional ,Immunohistochemistry ,Iron ,Magnetic Resonance Imaging ,Male ,Middle Aged ,Multiple Sclerosis ,Chronic Progressive ,Myelin Sheath ,General Science & Technology - Abstract
T2*-weighted multi-echo gradient-echo magnetic resonance imaging and its reciprocal R2* are used in brain imaging due to their sensitivity to iron content. In patients with multiple sclerosis who display pathological alterations in iron and myelin contents, the use of R2* may offer a unique way to untangle mechanisms of disease. Coronal slices from 8 brains of deceased multiple sclerosis patients were imaged using a whole-body 7.0 Tesla MRI scanner. The scanning protocol included three-dimensional (3D) T2*-w multi-echo gradient-echo and 2D T2-w turbo spin echo (TSE) sequences. Histopathological analyses of myelin and iron content were done using Luxol fast blue and proteolipid myelin staining and 3,3'-diaminobenzidine tetrahydrochloride enhanced Turnbull blue staining. Quantification of R2*, myelin and iron intensity were obtained. Variations in R2* were found to be affected differently by myelin and iron content in different regions of multiple sclerosis brains. The data shall inform clinical investigators in addressing the role of T2*/R2* variations as a biomarker of tissue integrity in brains of MS patients, in vivo.
- Published
- 2018